Loading clinical trials...
Loading clinical trials...
ECMO is widely used in patients with refractory respiratory and/or circulatory failure.The data shows that the incidence of bleeding and thrombotic events is still above 40%,and it is closely related ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beijing Chao Yang Hospital
NCT06593756 · ECMO Treatment, ARDS, and more
NCT06776549 · Out-of-hospital Cardiac Arrest (OHCA), ECMO Treatment, and more
NCT06868823 · Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO), and more
NCT07287813 · ICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIs
NCT07138599 · ECMO, Training Effectiveness, and more
Bing Sun
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions